Loading evaluation data…
Nanoscopic aggregates of alpha-synuclein (ɑSyn) have been observed in Parkinson's disease (PD). However, the processes that occur in vivo leading to the formation of these small aggregates are not well understood. We used ultra-sensitive single-molecule methods, including single molecule array (SIMOA), and super-resolution microscopy to quantify and characterize ɑSyn aggregates harvested from human brain samples, alongside a mouse model of synucleinopathy, using different tissue processing methods. While aggregate numbers did not differ between PD and control samples, larger aggregates were detected in PD brain samples. Moreover, different sub-populations of aggregates were obtained by different extraction methods, with diffusible and membrane-bound aggregates producing a more pronounced difference between disease and control samples. Our data suggest that ɑSyn aggregates slowly in the brain, leading to formation of larger aggregates in a sub-set of cells.
While aggregate numbers did not differ between PD and control samples, larger aggregates were detected in PD brain samples.
three donors per group limit disease-level inference, especially for the null aggregate-count result
Different sub-populations of aggregates were obtained by different extraction methods, with diffusible and membrane-bound aggregates producing a more pronounced difference between disease and control samples.
serial extraction supports method-dependent differences, though operational fractions and model fitting limit mechanistic interpretation
Our results show that two populations of ɑSyn aggregates, from healthy and diseased cells, exist in both control and PD brains.
the two cellular states are assumed by the fitted model rather than identified through cell-level measurements
the Line 61 mice had a significantly higher (∼10-fold) aggregate load
the reported comparison supports these preparations, but one mouse line and non-equivalent tissue sampling restrict generalisation
Derived from the full evaluation — not a separate score.
Strengths
Sequential soaking, homogenization, TrX, and sarkosyl extraction shows that aggregate yield and morphology depend strongly on tissue-processing method. The same human specimens contribute the sequential fractions.
↳ Results, Figures 1–4; STAR Methods, Human Tissue Collection and Sample Preparation
The paper identifies the 4B12 antibody, reports its catalogue number and RRID, explains the same-epitope aggregate-detection logic, and states the approximately 30 nm DNA-PAINT resolution threshold.
↳ Key Resources Table; Results, assay-rationale paragraphs; STAR Methods, SIMOA Assay and DNA-PAINT with SiMPull Imaging
The Discussion explicitly addresses the group’s earlier finding of smaller PD aggregates in the amygdala and distinguishes that region, disease context, and imaging method from the present study.
↳ Discussion, paragraph beginning “Our previous work imaged aggregates”
Limitations
Healthy- and diseased-state parameters are global within extraction methods, yet equality of healthy-cell removal rates across control and PD brains is presented as an empirical result. The Conclusion further treats the latent states as measured cell populations.
↳ STAR Methods, Distribution Fitting; Results, model-fitting paragraphs; Discussion, Conclusion
The headline PD-control comparison uses three donors per group, limiting disease-level inference and the interpretation of a null difference in aggregate number. This constraint is absent from the Limitations section.
↳ Table 1; STAR Methods, Experimental Model and Study Participant Details; Limitations of the Study
The Methods describe 24 male mice and the lack of females, while the Limitations section states that only female mice were used. This leaves the sex of the experimental cohort unresolved.
↳ STAR Methods, Experimental Model and Study Participant Details; Limitations of the Study
The strongest element is the systematic demonstration that extraction method changes the aggregate populations recovered, supported by serial processing and complementary SIMOA and DNA-PAINT measurements. The human disease comparison is exploratory because Table 1 contains only three PD and three control donors, making both broad disease inference and the aggregate-count null uncertain. The principal interpretive problem arises in Distribution Fitting and the Conclusion, where globally constrained two-state parameters are translated into claims about healthy and diseased cellular populations without cell-level measurement. Detailed protocols support reproducibility, but pooled imaging data, deferred statistical specifications, and contradictory reporting of mouse sex keep the overall quality below the well-supported band.
Nabu’s assessment, alongside the field’s view.
Are you an author of this paper?
Sound3.0
Confidence mediumThe study meaningfully combines serial extraction, SIMOA, DNA-PAINT/SiMPull, and distribution modelling to compare aggregate populations in human tissue and Line 61 mice. The advance remains bounded because the human comparison includes three PD and three control donors and the cellular mechanism is model-dependent.
“While aggregate numbers did not differ between PD and control samples, larger aggregates were detected in PD brain samples.”
Protocols, reagents, imaging resolution, serial extraction, and the distribution model are described in substantial detail. Confidence is reduced by pooled imaging observations with incompletely specified analytic nesting, the small biological samples, and inconsistent reporting of mouse sex.
“DNA-PAINT imaging was performed for 4 FoVs per well and two wells for each sample, from which the data were pooled.”
The experimental sequence and separation of aggregate quantity from morphology are readily followable. The Conclusion nonetheless converts a two-state model assumption into an affirmative claim about healthy and diseased cell populations, making the evidentiary status of that interpretation unclear.
“our results show that two populations of ɑSyn aggregates, from healthy and diseased cells, exist”
The Discussion engages relevant extraction-method research, prior amygdala findings, and known limitations of the Line 61 model. The stated limitations omit the decisive three-per-group human sample size and do not trace postmortem interval into the certainty of the morphology comparison.
“factors such as the postmortem interval may have an impact on tissue quality and aggregate morphology”
Concerns4 of 4 checks
The paper contains a material mismatch between the constraints of its two-state model and the presentation of model-derived equalities as empirical findings. Several additional within-text contradictions affect the reporting of extraction-specific results and the mouse cohort.
Competing interests and data availability are disclosed, but the supplied article does not include explicit human-tissue ethics/consent approval or animal-licensing statements.
Flags: 2 declared / 5 total
50 references in manuscript 50 of 50 checkable references found in an index
No retraction notice found in Retraction Watch.
Sources: Retraction Watch ✓
Where this paper’s evidence sits on the path from initial observation to real-world use.
The study provides mechanistic postmortem-tissue characterisation and model comparison under laboratory conditions. It does not test a diagnostic, therapeutic, or clinical workflow near deployment.
AI-generated, human-governed. Something look off? Contact us to request a review.